期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 13, 期 10, 页码 2390-2396出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2017.1364823
关键词
efficacy; house dust mite; immunotherapy; safety
资金
- National Natural Science Foundation of China [81401326, 81400128]
House dust mite (HDM) is a predominant source of indoor aeroallergen worldwide, which induces allergic diseases including allergic rhinoconjunctivitis, allergic asthma, atopic eczema and other allergic skin diseases. Allergen specific immunotherapy (AIT) is the only potential disease-modifying treatment of HDM allergic subjects. However, AIT remains underused due to no universally accepted allergen standardization and a shortage of rigorous clinical studies to confirm safety and efficacy. With the effort of doctors and researchers in allergy field, efficacy, safety, standardization and strategy of AIT are being continuously developed. This review presents the updated research based on recently published trials and meta-analyses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据